Circulating miRNAs predict cartilage damage in early rheumatoid arthritis treated with methotrexate plus adalimumab
Expert Talk on ” A unique target for managing proinflammatory response in different immunological disorders”
Anifrolumab Shows Durable Benefits in Achieving LLDAS and Remission in SLE: TULIP and Extension Trial Outcomes
New research reveals speckled and homogeneous patterns of antinuclear antibodies in rheumatoid arthritis
Genetic study unveils the association between gut bacteria and elevated risk of ankylosing spondylitis
